Isaac Blech
Founder, Celgene, ICOS, Nova Pharmaceutical, Pathogenesis, and Genetics Systems

Over the past thirty five years, Isaac Blech established some of the leading biotechnology companies in the world. These include Celgene Corporation, ICOS Corporation, Nova Pharmaceutical Corporation, Pathogenesis Corporation, and Genetics Systems Corporation. Collectively, these companies have produced major advances in a broad array of diseases including the diagnosis and treatment of cancer, chlamydia, sexual dysfunction, cystic fibrosis, and AIDS. Their combined value is over $110 billion.

Celgene is considered the leading cancer and hematology company in the world. ICOS Corporation discovered the drug Cialis, and was acquired by Eli Lilly for over $2.4 billion. At its height, Cialis was worth over $10 billion and has overtaken Viagra worldwide as the leading drug in this field. Nova Pharmaceutical Corporation developed a new treatment for brain cancer, and after merging with Scios, was purchased for $2 billion by Johnson and Johnson. Pathogeneses Corporation created TOBI for cystic fibrosis, the first inhaled antibiotic approved by the Food and Drug Administration, this breakthrough added 30 years of life to children with cystic fibrosis. Genetics Systems Corporation developed the first inexpensive and accurate test to diagnosis chlamydia, allowing millions of babies worldwide to be born to women who otherwise would have become sterile due to pelvic inflammatory disease. Genetics Systems was acquired for approximately 3% of Bristol Myers’ stock, now worth billions of dollars.

The trademark of Mr. Blech’s companies is the quality of the people associated with them. The Chief Executive Officers of these companies include former Chairmen and Presidents of Merck, Baxter International, Sterling Drugs,

The trademark of Mr. Blech’s companies is the quality of the people associated with them. The Chief Executive Officers of these companies include former Chairmen and Presidents of Merck, Baxter International, Sterling Drugs,
Monsanto, Amgen, Shire and Pfizer. The Boards of Directors of his companies have included Bill Gates, Founder of Microsoft, Don Kendall, who built the modern PepsiCo, Walter Wriston, who built the modern Citigroup, and Frank Cary who lead IBM in its prime, they also included twenty former Presidents and Chairmen of Fortune 500 companies, four former United States Cabinet Officers, two former United States Senators, a former supreme commander of NATO, a former Chairman of the Securities Exchange Commission, and a former President of the United States. The Scientific Advisory Boards of these companies included twenty members of the United States National Academy of Sciences and seven recipients of the Nobel Prize. Mr. Blech continues to actively create new companies today and currently has a portfolio of eight biotechnology companies which are at the cutting edge of the industry.